Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael Graner

Concepts (418)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Extracellular Vesicles
9
2024
148
3.680
Why?
Exosomes
11
2020
105
2.680
Why?
Glioma
10
2019
407
2.420
Why?
Cancer Vaccines
17
2018
166
1.950
Why?
Molecular Chaperones
17
2013
196
1.820
Why?
Brain Neoplasms
12
2022
1267
1.700
Why?
Tumor Microenvironment
5
2024
669
1.670
Why?
Brain Ischemia
2
2025
343
1.330
Why?
Neoplasms
11
2021
2681
1.310
Why?
Multiple Sclerosis
8
2023
460
1.260
Why?
Cytokines
7
2024
2080
1.050
Why?
Antigens, Neoplasm
7
2018
316
0.950
Why?
Glioblastoma
4
2022
341
0.940
Why?
Unfolded Protein Response
3
2016
59
0.930
Why?
Interleukin-6
5
2025
785
0.930
Why?
Immunoglobulin G
7
2023
898
0.930
Why?
HSP90 Heat-Shock Proteins
4
2015
46
0.920
Why?
Proteome
6
2024
469
0.920
Why?
Chordoma
1
2024
14
0.890
Why?
Immune Tolerance
2
2018
366
0.880
Why?
Cell Movement
7
2024
969
0.870
Why?
Oligoclonal Bands
4
2022
20
0.870
Why?
HSP70 Heat-Shock Proteins
7
2015
74
0.860
Why?
Osteoblasts
1
2024
131
0.840
Why?
Heat-Shock Proteins
8
2013
142
0.830
Why?
Stroke
2
2023
1136
0.810
Why?
Gene Expression Regulation, Neoplastic
7
2024
1388
0.790
Why?
Epithelial-Mesenchymal Transition
1
2024
210
0.780
Why?
Ischemic Attack, Transient
1
2023
67
0.740
Why?
Cell Line, Tumor
19
2024
3392
0.690
Why?
Extracellular Space
4
2015
129
0.690
Why?
Proteomics
6
2024
1110
0.690
Why?
Immunity
4
2018
140
0.680
Why?
Meningioma
1
2022
94
0.680
Why?
Antineoplastic Agents
7
2021
2152
0.670
Why?
Meningeal Neoplasms
1
2022
101
0.670
Why?
Astrocytes
2
2019
216
0.610
Why?
Vacuolar Proton-Translocating ATPases
1
2019
15
0.600
Why?
Antigen Presentation
4
2018
219
0.600
Why?
Immunomodulation
2
2018
99
0.580
Why?
Neoplasm Proteins
2
2016
429
0.580
Why?
RNA, Neoplasm
1
2018
79
0.560
Why?
MicroRNAs
3
2018
675
0.530
Why?
T-Lymphocytes
4
2018
1986
0.500
Why?
Brain Injuries
1
2021
501
0.490
Why?
Calreticulin
2
2013
28
0.450
Why?
Signal Transduction
8
2020
5086
0.440
Why?
Cell Proliferation
7
2018
2480
0.440
Why?
Humans
59
2025
138651
0.430
Why?
Animals
42
2023
37217
0.420
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2013
19
0.410
Why?
Mice, Inbred BALB C
15
2014
1262
0.400
Why?
Leukocytes, Mononuclear
1
2015
571
0.380
Why?
Dog Diseases
1
2013
65
0.380
Why?
Autoantibodies
1
2020
1456
0.370
Why?
Heat-Shock Response
2
2015
75
0.370
Why?
Cerebellar Neoplasms
1
2012
162
0.330
Why?
Stress, Physiological
1
2013
450
0.320
Why?
Medulloblastoma
1
2012
202
0.320
Why?
Dendritic Cells
12
2008
491
0.310
Why?
Mice
26
2023
17814
0.310
Why?
Transcription Factors
2
2014
1697
0.310
Why?
Mycobacterium tuberculosis
7
2015
315
0.300
Why?
Drug Resistance, Neoplasm
2
2013
801
0.290
Why?
Tuberculosis
4
2015
280
0.280
Why?
Carrier Proteins
2
2009
737
0.270
Why?
Transforming Growth Factor beta
4
2024
488
0.260
Why?
Peptides
5
2024
976
0.260
Why?
Isoelectric Focusing
3
2015
30
0.250
Why?
Neoplasms, Experimental
3
2006
174
0.250
Why?
Lymphocyte Activation
5
2012
1148
0.250
Why?
Histocompatibility Antigens Class I
3
2018
205
0.250
Why?
Interferon-gamma
8
2015
786
0.240
Why?
Case-Control Studies
5
2021
3523
0.230
Why?
Immunotherapy
3
2021
634
0.230
Why?
Oligopeptides
4
2007
266
0.230
Why?
Female
30
2025
73763
0.230
Why?
Tetraspanin 28
1
2024
6
0.220
Why?
alpha-Synuclein
1
2024
42
0.220
Why?
Amino Acid Sequence
6
2020
2155
0.220
Why?
Fusion Proteins, bcr-abl
4
2007
70
0.210
Why?
Albumins
1
2004
115
0.210
Why?
Middle Aged
14
2025
33604
0.210
Why?
Apoptosis
5
2023
2546
0.210
Why?
Integrins
3
1998
95
0.210
Why?
Leukemia, B-Cell
2
2000
13
0.200
Why?
Multiple Sclerosis, Chronic Progressive
1
2023
28
0.200
Why?
Sensitivity and Specificity
3
2025
1941
0.200
Why?
Neuroblastoma
2
2023
159
0.190
Why?
Multiple Sclerosis, Relapsing-Remitting
1
2023
76
0.190
Why?
Aged, 80 and over
3
2025
7677
0.190
Why?
Drosophila Proteins
3
1998
201
0.190
Why?
Transferases
1
2022
31
0.190
Why?
Tuberculosis, Pleural
2
2014
7
0.190
Why?
Membrane Glycoproteins
4
2015
499
0.180
Why?
Tuberculosis, Pulmonary
3
2012
141
0.180
Why?
Lung Neoplasms
2
2013
2527
0.180
Why?
Melanoma
2
2024
756
0.180
Why?
Male
19
2025
68260
0.180
Why?
Organ Specificity
2
2020
310
0.180
Why?
Leukemia
4
2006
239
0.180
Why?
Peptide Fragments
4
2020
693
0.170
Why?
Epitopes
2
2020
475
0.170
Why?
Blotting, Western
4
2009
1230
0.170
Why?
Tissue Plasminogen Activator
1
2023
229
0.170
Why?
Xenograft Model Antitumor Assays
4
2013
870
0.170
Why?
Cell Extracts
3
2006
21
0.170
Why?
Biomarkers
5
2025
4092
0.170
Why?
Ultracentrifugation
1
2020
52
0.170
Why?
Laser Capture Microdissection
1
2020
32
0.170
Why?
Extracellular Matrix Proteins
2
1998
157
0.160
Why?
Plasma Cells
1
2020
73
0.160
Why?
Tumor Cells, Cultured
7
2007
956
0.160
Why?
Aged
7
2025
24024
0.160
Why?
CD4-Positive T-Lymphocytes
3
2012
1098
0.160
Why?
Antibody Specificity
1
2020
187
0.160
Why?
Immunosuppressive Agents
1
2004
849
0.160
Why?
Peptide Library
1
2020
95
0.160
Why?
Protein Transport
2
2019
444
0.160
Why?
Virus Latency
1
2020
79
0.150
Why?
Prognosis
2
2021
3984
0.150
Why?
T-Lymphocytes, Cytotoxic
8
2015
174
0.150
Why?
Cells, Cultured
6
2015
4181
0.150
Why?
Epstein-Barr Virus Infections
1
2020
98
0.150
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
2007
125
0.150
Why?
Bacteriophages
1
2020
98
0.150
Why?
Receptors, Purinergic
1
2018
19
0.150
Why?
Lymphoma, B-Cell
1
2000
127
0.150
Why?
Tenascin
1
1998
15
0.150
Why?
Transcription, Genetic
3
2014
1470
0.140
Why?
Laminin
1
1998
71
0.140
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2017
984
0.140
Why?
Receptors, Fc
1
2018
55
0.140
Why?
Antigen-Presenting Cells
1
2018
157
0.140
Why?
Milk
1
2018
123
0.140
Why?
Alzheimer Disease
1
2024
564
0.140
Why?
DNA, Viral
1
2020
365
0.140
Why?
Alternative Splicing
2
2006
227
0.140
Why?
Drug Carriers
1
2018
126
0.140
Why?
Immune System
1
2019
181
0.140
Why?
Cell Hypoxia
2
2015
230
0.130
Why?
Nanoparticles
2
2020
469
0.130
Why?
Biological Transport
1
2018
403
0.130
Why?
Ovarian Neoplasms
2
2017
562
0.130
Why?
Autoantigens
1
2020
422
0.130
Why?
Prostatic Neoplasms
2
2015
1044
0.130
Why?
DNA Methylation
1
2022
629
0.130
Why?
Time Factors
2
2025
6851
0.130
Why?
Host-Pathogen Interactions
1
2020
368
0.130
Why?
Antigens, Bacterial
2
2015
125
0.130
Why?
Herpesvirus 3, Human
1
2020
331
0.120
Why?
Inflammation
2
2019
2850
0.120
Why?
Adenosine Triphosphate
1
2018
489
0.120
Why?
Mass Spectrometry
2
2016
734
0.120
Why?
Protein Array Analysis
1
2015
56
0.120
Why?
Antigens, Surface
1
2015
154
0.120
Why?
Lymphocytes
1
2017
395
0.120
Why?
DNA
1
2022
1438
0.110
Why?
Brain
3
2020
2792
0.110
Why?
Sequence Analysis, RNA
1
2017
448
0.110
Why?
Neurons
2
2022
1601
0.110
Why?
Granuloma
1
2015
97
0.110
Why?
Azides
1
2014
47
0.110
Why?
Alkynes
1
2014
61
0.110
Why?
RNA, Messenger
5
2020
2815
0.110
Why?
Acute Lung Injury
1
2017
299
0.110
Why?
Click Chemistry
1
2014
50
0.110
Why?
Lung
3
2017
4106
0.110
Why?
BCG Vaccine
2
2010
24
0.100
Why?
Adherens Junctions
1
2013
25
0.100
Why?
Interferon-gamma Release Tests
1
2014
32
0.100
Why?
Basigin
1
2013
25
0.100
Why?
Intestinal Mucosa
1
2018
620
0.100
Why?
Flow Cytometry
3
2012
1192
0.100
Why?
Pleural Effusion
1
2014
57
0.100
Why?
Antineoplastic Agents, Alkylating
1
2013
70
0.100
Why?
Adult
13
2024
38201
0.100
Why?
Dacarbazine
1
2013
98
0.100
Why?
Histocompatibility Antigens Class II
2
2013
366
0.100
Why?
Lipogenesis
1
2013
61
0.100
Why?
Triglycerides
1
2015
513
0.100
Why?
Matrix Metalloproteinase 9
1
2013
133
0.100
Why?
Drosophila
3
1998
152
0.100
Why?
Endoplasmic Reticulum Stress
1
2013
117
0.100
Why?
Hepatocyte Nuclear Factor 4
1
2012
14
0.100
Why?
ErbB Receptors
2
2006
609
0.100
Why?
Prostate
1
2013
173
0.100
Why?
Transforming Growth Factor beta1
1
2013
164
0.090
Why?
Neoplasm Grading
1
2013
305
0.090
Why?
Mice, Inbred C57BL
6
2017
5798
0.090
Why?
Liver
2
2013
1805
0.090
Why?
Tumor Burden
1
2013
309
0.090
Why?
Dogs
1
2013
426
0.090
Why?
B-Lymphocytes
2
2022
855
0.090
Why?
Neutrophils
1
2017
1274
0.090
Why?
Treatment Outcome
3
2023
10923
0.090
Why?
B-Lymphocyte Subsets
1
2012
77
0.090
Why?
Cell Line
4
2020
2876
0.090
Why?
Epithelial Cells
1
2017
1102
0.090
Why?
Mice, Nude
3
2007
688
0.090
Why?
Cell Survival
2
2012
1123
0.090
Why?
Phenotype
3
2018
3139
0.090
Why?
Gene Regulatory Networks
1
2013
309
0.090
Why?
Enzyme-Linked Immunospot Assay
1
2010
37
0.080
Why?
Th17 Cells
1
2012
107
0.080
Why?
Radiography
1
2013
841
0.080
Why?
RNA-Binding Proteins
1
2014
431
0.080
Why?
Interleukin-17
1
2011
118
0.080
Why?
Oxygen
1
2015
977
0.080
Why?
Latent Tuberculosis
1
2010
68
0.080
Why?
Immunohistochemistry
3
2009
1731
0.080
Why?
Receptors, Interleukin-6
1
2009
46
0.080
Why?
Immunity, Innate
1
2015
824
0.080
Why?
Interleukins
1
2011
246
0.080
Why?
Tissue Array Analysis
1
2009
51
0.080
Why?
Mycobacterium bovis
1
2009
17
0.080
Why?
Receptors, Vascular Endothelial Growth Factor
2
2008
108
0.080
Why?
T-Lymphocytes, Helper-Inducer
1
2009
136
0.080
Why?
Cross-Priming
1
2008
16
0.070
Why?
Enzyme-Linked Immunosorbent Assay
3
2023
849
0.070
Why?
Electrophoresis, Gel, Two-Dimensional
1
2008
112
0.070
Why?
Antigens, Differentiation
1
2008
82
0.070
Why?
Toll-Like Receptor 2
1
2009
117
0.070
Why?
Adaptor Proteins, Signal Transducing
2
2009
428
0.070
Why?
Carcinoma, Lewis Lung
2
2005
15
0.070
Why?
Neoplasm Transplantation
3
2006
250
0.070
Why?
Blood-Brain Barrier
1
2008
141
0.070
Why?
Immunization
3
2015
405
0.070
Why?
Immunotherapy, Active
1
2007
9
0.070
Why?
Tissue Extracts
1
2007
20
0.070
Why?
DNA-Binding Proteins
1
2014
1471
0.070
Why?
Angiogenesis Inhibitors
1
2008
230
0.060
Why?
Hypoxia
1
2013
1149
0.060
Why?
Tissue Distribution
2
2018
330
0.060
Why?
Cell Membrane
1
2009
716
0.060
Why?
Vitamin E
1
2005
122
0.060
Why?
T-Lymphocyte Subsets
1
2007
415
0.060
Why?
Spleen
2
2004
523
0.050
Why?
Integrin alpha Chains
3
1998
24
0.050
Why?
Amyloidogenic Proteins
1
2024
16
0.050
Why?
Quinazolines
1
2005
249
0.050
Why?
Piperidines
1
2005
216
0.050
Why?
Molecular Sequence Data
3
2015
2923
0.050
Why?
Central Nervous System Neoplasms
1
2005
165
0.050
Why?
Kinetics
2
2006
1645
0.050
Why?
Neoplasm Invasiveness
2
2015
501
0.050
Why?
Disease Models, Animal
1
2013
4315
0.050
Why?
Immunotherapy, Adoptive
2
2004
349
0.050
Why?
Plasma
1
2024
220
0.050
Why?
Interleukin-12
3
2008
123
0.050
Why?
Piperazines
1
2004
345
0.050
Why?
Recombinant Proteins
2
2020
1352
0.040
Why?
Survival Analysis
2
2006
1309
0.040
Why?
Head and Neck Neoplasms
1
2006
549
0.040
Why?
Hyperthermia, Induced
1
2002
120
0.040
Why?
Carcinoma, Squamous Cell
1
2006
638
0.040
Why?
Cell Division
1
2003
794
0.040
Why?
Chromatography
1
2000
24
0.040
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
12
0.040
Why?
Chemical Precipitation
1
2020
38
0.040
Why?
Pyrimidines
1
2004
472
0.040
Why?
Dose-Response Relationship, Drug
2
2005
2049
0.040
Why?
Lymphocyte Culture Test, Mixed
3
2007
51
0.040
Why?
Injections, Spinal
1
2020
108
0.040
Why?
Electrophoresis, Polyacrylamide Gel
1
2000
336
0.040
Why?
bcl-X Protein
1
2020
43
0.040
Why?
Lipids
1
2004
675
0.040
Why?
Immediate-Early Proteins
1
2020
49
0.040
Why?
Hematopoietic Stem Cell Transplantation
1
2006
661
0.040
Why?
Complement System Proteins
1
2023
319
0.040
Why?
Electron Transport Complex IV
1
2020
60
0.040
Why?
3T3 Cells
1
2000
164
0.040
Why?
Vaccination
1
2008
1437
0.040
Why?
Herpesvirus 4, Human
1
2020
165
0.040
Why?
Ligands
2
1998
665
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2000
150
0.040
Why?
Viral Envelope Proteins
1
2020
97
0.040
Why?
China
2
2010
214
0.040
Why?
Up-Regulation
2
2013
851
0.040
Why?
Caspase 3
1
2020
249
0.040
Why?
Carbocyanines
1
2018
33
0.040
Why?
Ribonucleoproteins
1
2000
104
0.040
Why?
Proto-Oncogene Proteins c-bcl-2
1
2020
234
0.040
Why?
Calcium-Binding Proteins
1
2000
215
0.040
Why?
Biological Availability
1
2018
137
0.040
Why?
Permeability
1
2018
161
0.040
Why?
Protein Conformation
2
1998
936
0.040
Why?
Solubility
1
2018
242
0.040
Why?
RNA Transport
1
2017
23
0.030
Why?
Young Adult
5
2014
13305
0.030
Why?
Poly(ADP-ribose) Polymerases
1
2017
98
0.030
Why?
Th1 Cells
2
2012
139
0.030
Why?
Fluorescent Dyes
1
2018
320
0.030
Why?
Cell Adhesion
1
1998
466
0.030
Why?
Gene Knockdown Techniques
1
2017
329
0.030
Why?
Administration, Oral
1
2018
788
0.030
Why?
Gene Expression Regulation
2
2020
2590
0.030
Why?
Antibodies, Viral
1
2020
649
0.030
Why?
Cattle
1
2018
991
0.030
Why?
Blood Proteins
1
2017
244
0.030
Why?
Drug Screening Assays, Antitumor
2
2007
193
0.030
Why?
Cell Communication
1
2017
316
0.030
Why?
Antibodies, Monoclonal
3
2008
1436
0.030
Why?
Fetus
1
2020
799
0.030
Why?
Muscle Contraction
1
1998
431
0.030
Why?
Pharmaceutical Vehicles
1
2014
12
0.030
Why?
HSP72 Heat-Shock Proteins
2
2007
32
0.030
Why?
Fibroblasts
1
2020
1003
0.030
Why?
Cycloaddition Reaction
1
2014
28
0.030
Why?
Chemistry, Pharmaceutical
1
2014
103
0.030
Why?
Injections, Intravenous
1
2014
202
0.030
Why?
Fluorescence
1
2015
159
0.030
Why?
Protein Binding
1
2000
2225
0.030
Why?
Antibiotics, Antineoplastic
1
2014
122
0.030
Why?
Tetraspanins
1
2013
19
0.030
Why?
Annexin A2
1
2013
16
0.030
Why?
Phosphatidylcholines
1
2014
136
0.030
Why?
Copper
1
2014
111
0.030
Why?
Metalloproteases
1
2013
42
0.030
Why?
Choline
1
2014
131
0.030
Why?
Cross-Linking Reagents
1
2014
208
0.030
Why?
Epitopes, T-Lymphocyte
1
2015
184
0.030
Why?
Membrane Proteins
1
2000
1145
0.030
Why?
Bone Marrow Cells
2
2007
325
0.030
Why?
Particle Size
1
2014
391
0.030
Why?
Surface Properties
1
2014
410
0.030
Why?
Feedback, Physiological
1
2013
81
0.020
Why?
Coculture Techniques
1
2013
241
0.020
Why?
Liposomes
1
2014
218
0.020
Why?
Doxorubicin
1
2014
348
0.020
Why?
CD5 Antigens
1
2012
9
0.020
Why?
Ionomycin
1
2012
22
0.020
Why?
Antigens, CD1d
1
2012
68
0.020
Why?
Tetradecanoylphorbol Acetate
1
2012
156
0.020
Why?
Lymphocyte Count
1
2012
166
0.020
Why?
Cell Aggregation
1
2011
25
0.020
Why?
Pneumonia
1
2017
644
0.020
Why?
Drug Delivery Systems
1
2014
359
0.020
Why?
Infant, Newborn
1
2023
6144
0.020
Why?
Antigens, CD19
1
2012
129
0.020
Why?
Phosphorylation
2
2005
1760
0.020
Why?
Interleukin-2
1
2012
451
0.020
Why?
Prospective Studies
2
2014
7554
0.020
Why?
Monophenol Monooxygenase
1
2008
8
0.020
Why?
Immunoenzyme Techniques
1
2009
209
0.020
Why?
Radioimmunotherapy
1
2008
21
0.020
Why?
Predictive Value of Tests
1
2014
2030
0.020
Why?
Genes, Insect
2
1998
22
0.020
Why?
Interleukin-8
1
2009
271
0.020
Why?
Vaccines, DNA
1
2008
32
0.020
Why?
Vascular Endothelial Growth Factors
1
2008
80
0.020
Why?
Immunization, Passive
1
2008
90
0.020
Why?
Vaccines, Subunit
1
2008
50
0.020
Why?
Wings, Animal
2
1998
35
0.020
Why?
Immunotoxins
1
2008
55
0.020
Why?
Adolescent
3
2012
21564
0.020
Why?
Down-Regulation
1
2009
635
0.020
Why?
Calbindin 2
1
2007
8
0.020
Why?
S100 Calcium Binding Protein G
1
2007
8
0.020
Why?
HLA-A2 Antigen
1
2007
49
0.020
Why?
Animals, Genetically Modified
2
1998
242
0.020
Why?
Egg Proteins
1
2007
21
0.020
Why?
Ovalbumin
1
2007
194
0.020
Why?
Tumor Necrosis Factor-alpha
1
2012
1244
0.020
Why?
Cytotoxicity, Immunologic
1
2007
224
0.020
Why?
Biomarkers, Tumor
1
2013
1224
0.020
Why?
Transplantation, Isogeneic
1
2006
16
0.020
Why?
Antigen-Antibody Reactions
1
2006
54
0.020
Why?
Transplantation, Heterologous
1
2006
192
0.020
Why?
Drug Synergism
1
2007
368
0.020
Why?
Mutation
3
2006
3987
0.020
Why?
Hot Temperature
1
2008
393
0.010
Why?
Dosage Forms
1
2005
9
0.010
Why?
Tocopherols
1
2005
26
0.010
Why?
alpha-Macroglobulins
1
2005
24
0.010
Why?
Ki-67 Antigen
1
2005
111
0.010
Why?
Ultrasonics
1
2005
50
0.010
Why?
T-Lymphocytes, Regulatory
1
2008
386
0.010
Why?
Mitogen-Activated Protein Kinase 3
1
2005
150
0.010
Why?
Lymphocytes, Tumor-Infiltrating
1
2007
205
0.010
Why?
Mitogen-Activated Protein Kinase 1
1
2005
183
0.010
Why?
T-Cell Antigen Receptor Specificity
1
2004
51
0.010
Why?
HeLa Cells
1
2006
637
0.010
Why?
Imatinib Mesylate
1
2004
80
0.010
Why?
Neovascularization, Pathologic
1
2005
296
0.010
Why?
Ependymoma
1
2005
163
0.010
Why?
In Vitro Techniques
1
2005
1092
0.010
Why?
Benzamides
1
2004
213
0.010
Why?
Cell-Free System
1
2003
55
0.010
Why?
Chaperonin 60
1
2002
13
0.010
Why?
CD40 Antigens
1
2003
89
0.010
Why?
Protein Folding
1
2003
276
0.010
Why?
Drug Evaluation, Preclinical
1
2002
195
0.010
Why?
Severity of Illness Index
1
2009
2851
0.010
Why?
Tomography, X-Ray Computed
1
2012
2698
0.010
Why?
Combined Modality Therapy
1
2004
1235
0.010
Why?
Adjuvants, Immunologic
1
2002
237
0.010
Why?
CD8-Positive T-Lymphocytes
1
2007
905
0.010
Why?
Immunity, Cellular
1
2002
269
0.010
Why?
Gene Expression Profiling
1
2006
1746
0.010
Why?
Cell Differentiation
1
2007
1992
0.010
Why?
Pupa
1
1998
12
0.010
Why?
Genes, Lethal
1
1998
30
0.010
Why?
Recombinant Fusion Proteins
1
2001
663
0.010
Why?
Crosses, Genetic
1
1998
133
0.010
Why?
DNA, Complementary
1
1998
274
0.010
Why?
Abdomen
1
1998
135
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2006
1742
0.010
Why?
Sequence Homology, Amino Acid
1
1998
391
0.010
Why?
Larva
1
1998
234
0.010
Why?
Cytoplasm
1
1998
270
0.010
Why?
Muscles
1
1998
332
0.010
Why?
HIV Infections
1
2010
2941
0.010
Why?
Retina
1
1998
305
0.010
Why?
Base Sequence
1
1998
2174
0.010
Why?
Gene Expression Regulation, Developmental
1
1998
873
0.010
Why?
Risk Factors
1
2006
10252
0.010
Why?
Retrospective Studies
1
2006
15909
0.000
Why?
Graner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)